Magnolia, AR, United States of America

Peter Klucar

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 40(Granted Patents)


Location History:

  • Dallas, TX (US) (2015)
  • Magnolia, AR (US) (2021 - 2023)

Company Filing History:


Years Active: 2015-2023

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter Klucar

Introduction

Peter Klucar is a notable inventor based in Magnolia, Arkansas, who has made significant contributions to the field of biotechnology. With a focus on cancer research, he has developed innovative solutions that aim to improve vaccine delivery and antigen presentation.

Latest Patents

Peter Klucar holds 3 patents, with his latest inventions centered around fusion proteins that incorporate an anti-CD40 antibody and cancer antigens. These patents detail compositions and methods for expressing, secreting, and utilizing novel compositions as vaccines and antigen delivery vectors. The inventions aim to enhance the delivery of antigens to antigen-presenting cells, utilizing anti-CD40 antibodies or their fragments linked to various antigenic peptides, including humanized antibodies.

Career Highlights

Klucar's work is primarily associated with the Baylor Research Institute, where he has been instrumental in advancing research in immunology and cancer treatment. His innovative approaches have garnered attention in the scientific community, contributing to the development of new therapeutic strategies.

Collaborations

Throughout his career, Peter Klucar has collaborated with esteemed colleagues such as Gerard Zurawski and Jacques F. Banchereau. These partnerships have fostered a collaborative environment that enhances the research and development of groundbreaking medical solutions.

Conclusion

Peter Klucar's contributions to biotechnology and cancer research exemplify the impact of innovative thinking in addressing complex medical challenges. His patents and collaborative efforts continue to pave the way for advancements in vaccine technology and cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…